Dis-Chem Pharmacies Ltd Formerly known as Dis-Chem Pharmacies. Dis-Chem Pharmacies Limited, formerly Dis-Chem Pharmacies Proprietary Limited, is a pharmacy company in South Africa. In addition to pharmaceutical products and services, its retail pharmacies also sell personal care and beauty, healthcare and nutrition and baby care products, as well as confectionary, dry grocery, household and other ancillary products. It offers dispensary products, including diagnostics, first aid, and mobility and incontinence; beauty products, including beauty accessories, color cosmetics, face care, fragrance and skin care; toiletries products, including bath care, body care, foot care, hair care, oral care and shaving; electrical products, including heating and cooling, household and lifestyle, and household products, including cleaners and fresheners, insecticides, kitchen tools, purifiers and veterinary. It also offers vitamin products, sports supplements, and sports equipment and aids, and foods and specialized diet. It has over 101 stores in South Africa.
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
Direct and indirect costs from two consecutive strikes over the last two years will leave DCP's FY '20 earnings on FY '17 earnings despite the Group growing revenue by c.13% pa. Adjusting for the once-off impacts, we estimate the Group would have grown earnings in line with revenue. This is despite low inflation and the additional costs from aggressive store expansion constraining margins. In our view, the Group's earnings trajectory is normalising. DCP's store expansion is moderating and maturing trading densities will contribute to a four-year revenue CAGR of c.14%. According to our est...
Dis-Chem (DCP) were recently hosts to sell-side analysts on a site visit to its three stores in the Greenstone node in Gauteng, to explain its store co-location strategies. Management also gave detail on sizable once-off items and rebate timing issues from the last 12 months, which will unwind in FY '20 and optically skew the company's underlying earnings growth trajectory. DCP's store rollout strategy over the last two years identifies greenfield locations and regions with existing mature stores (co-location). The co-location roll-out strategy is also a pre-emptive offense against peers al...
A director at Dis-Chem Pharmacies Limited sold 1,000,000 shares at 22.425ZAR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. T...
The independent financial analyst theScreener just awarded an improved star rating to ABSA GROUP (ZA), active in the Money Center Banks industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 4 out of 4 possible stars. With regard to its market behaviour, it remains unchanged and can be qualified as risky. theScreener considers that these elements allow slightly upgrading its rating to Neutral. As of the analysis date September 18, 2020, the closing price was ZAR 85.58 and its expected value was estimated at ZAR 83.66.
YUM! BRANDS (US), a company active in the Restaurants & Bars industry, now shows a lower overall rating. The independent financial analyst theScreener just confirmed the fundamental rating of 4 stars out of 4, as well as the stock market behaviour of the title as moderately risky. However, environmental deterioration penalises the general evaluation, which is downgraded to Neutral. As of the analysis date September 18, 2020, the closing price was USD 92.11 and its expected value was estimated at USD 93.26.
The independent financial analyst theScreener just requalified the general evaluation of XILINX (US), active in the Semiconductors industry. As regards its fundamental valuation, the title still shows 0 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date September 18, 2020, the closing price was USD 100.72 and its target price was estimated at USD 84.90.
Unfortunately, this report is not available for the investor type or country you selected.Browse all ResearchPool reports
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.